Table 1

Data used to inform sample frame

Data typeSourceInformation providedTime frame
Household survey dataProvided by authors of Reference 25.% of patients consuming medicine, by API and dose2018
Detailed distribution or dispensing dataSecondary data provided by facilitiesVolumes distributed or dispensed by API, dose, brand and month: district warehouse; two primary health centres; one private distributor; two pharmaciesApril–October 2020
National aggregate sales volumeIQVIA public healthSales volume by API and dose, by INN status and outlet sector (hospital or retail).April–October 2020
Listing of pharmaciesDistrict health office, verified by research teamLocation of pharmacies and medicine shops in eight study villages and four neighbouring market centres*; private healthcare providers in eight study villages2019 data received March 2020, verified October 2020
Listing of healthcare providers and medicine shopsInternet search and public directories, verified by research teamLocation of private healthcare providers and medicine shops in eight study villagesOctober–November 2020
Rapid survey of pharmacies and medicine shopsPrimary dataEstimate of patients served per day with any study medicineOctober–November 2020
Rapid survey of healthcare providersPrimary dataEstimate of patients served per day with any study medicine, medicines sold, source of medicinesNovember–December 2020
  • *These bordering locations are frequent shopping destinations for residents of the eight villages.

  • API, active pharmaceutical ingredient; INN, international non-proprietary name.